Effect of QRS duration Normalized for Left Ventricular Size on Cardiac Resynchronization Therapy in Heart Failure Patients with a Narrow (<130 ms) QRS complex: A Subgroup Analysis of the EchoCRT Trial

27 August 2017 (08:30 - 18:00)

Organised by:

About the speaker

Doctor Niraj Varma

Cleveland Clinic, Cleveland (United States of America)

6 More presentations in this session

Presentation thumbnail

REDEFINE trial: a double-blind, randomized trial with losartan to study RV dysfunction after repair of tetralogy of Fallot

Doctor J. Bokma (Amsterdam, NL)

Presentation thumbnail

A Randomized Controlled Trial Evaluating the Efficacy of Long-term Use of Beta-blocker in Patients with ST-segment Elevation Myocardial Infarction treated with Primary Percutaneous Coronary Interventi

Mr H. Watanabe (Wakayama, JP)

Presentation thumbnail

Efficacy and Safety of Evolocumab Compared With Continued Lipoprotein Apheresis: Results of a Randomised, Controlled, Open-Label Study

Doctor P. Moriarty (Kansas City, US)

Presentation thumbnail

Intensive Longterm Prevention Program vs. Usual Care After Acute Myocardial Infarctions - The IPP study

Professor H. Wienbergen (Bremen, DE)

Presentation thumbnail

Innovative mobile Health (mHealth) technology integrating clinical decision support and patient involvement to improve clinical management of patients with atrial fibrillation

Professor Y. Guo (Beijing, CN)

Access the full session

Session thumbnail

Late-Breaking Science Posters

The Event

ESC Congress 2017

27 August 2017 08:30 CET

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources